Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.
Journal: Hepatology (Baltimore, Md.)
Published: November 29, 2018
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
Journal: Journal of hepatology
Published: June 26, 2018
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.
Journal: Hepatology (Baltimore, Md.)
Published: March 14, 2018
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
Journal: Gastroenterology
Published: March 12, 2018
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 02, 2018
Showing 1-6 of 6
Last Updated: 09/26/2026